100 mean BMI was 26.41 kg/m2 (SD 5.049). Patients with a histopathological diagnosis of adenomyosis more often had a history of endometriosis compared to patients without adenomyosis diagnosis (56.4% vs. 38.5%, p = 0.014). Patients with adenomyosis also had fibroids more often that patients without adenomyosis (54.7% vs. 34.6%, p = 0.006). Additionally, patients with adenomyosis were reported to have more dysmenorrhoea compared to patients without (66.2% vs. 44.3%, p = 0.011). Table 4.1. Patient baseline characteristics. Histopathology: Adenomyosis (n=78) Histopathology: No adenomyosis (n=117) P-value Demographics Age at MRI 43.51 ± 7.771 42.97 ± 9.724 0.357 BMI Intoxications 27.70 ± 4.715 26.41 ± 5.049 0.076 Smoking 11 (14.1%) 24 (20.5%) 0.487 Medical history History of curettage 10 (12.8%) 12 (10.3%) 0.579 Gravidity 2.34 ± 1.238 2.38 ± 1.237 0.816 Parity 1.61 ± 1.014 1.65 ± 1.107 0.827 History of caesarean section 17 (21.8%) 28 (23.9%) 0.889 Regular cycle 28 (35.9%) 41 (35.0%) 0.774 Hormonal medication* 35 (44.9%) 59 (50.4%) 0.447 Endometriosis ∞ 44 (56.4%) 45 (38.5%) 0.014 Uterine Fibroids ∞ 27 (34.6%) 64 (54.7%) 0.006 Symptoms Dysmenorrhea 51 (65.4%) 51 (43.6%) 0.011 AUB 27 (34.6%) 38 (32.5%) 0.932 Chronic pain 29 (37.2%) 41 (35.0%) 0.934 Subfertility 13 (16.7%) 9 (7.7%) 0.150 Dyschezia 17 (21.8%) 20 (17.1%) 0.702 Dyspareunia 23 (29.5%) 39 (33.3%) 0.818 BMI = Body Mass Index; MRI = Magnetic Resonance Imaging; AUB = Abnormal Uterine Bleeding; *i.e., progesterone only pill, GnRH agonist, combined oral contraceptive pill, intrauterine device with levonorgestrel. ∞ diagnosis based on MRI or laparoscopy.
RkJQdWJsaXNoZXIy MTk4NDMw